Skip to main content
Top
Published in: Pituitary 1/2024

25-11-2023 | Hyponatremia

Incidence of postoperative hyponatremia after endoscopic endonasal pituitary transposition for skull base pathologies

Authors: Francesca Galbiati, Sharini Venugopal, Hussam Abou-Al-Shaar, Georgios A. Zenonos, Paul A. Gardner, Pouneh K. Fazeli, Hussain Mahmud

Published in: Pituitary | Issue 1/2024

Login to get access

Abstract

Purpose

Pituitary transposition is a novel surgical approach to access the retroinfundibular space and interpeduncular cistern. Few studies have evaluated post-surgical outcomes, including incidence of hyponatremia, following pituitary transposition.

Methods

This is a retrospective study including 72 patients who underwent endoscopic endonasal surgery involving pituitary transposition for non-pituitary derived tumors over a decade at the University of Pittsburgh Medical Center. Anterior pituitary deficiencies and replacement therapy, tumor pathology and pre-operative serum sodium (Na) were recorded. Na was assessed at postoperative day 1, 3, 5, 7, and 10. Anatomical/surgical parameters included sellar height, sellar access angle to approach the tumor, and cranial extension of the tumor above the sellar floor (B) compared to the height of the gland (A) (B/A). T-test (normally distributed variables) and Wilcoxon rank-sum test (not-normally distributed) were applied for mean comparison. Logistic regression analyzed correlations between anatomical/surgical parameters and postoperative hyponatremia.

Results

55.6% of patients developed post-operative transient hyponatremia. Two patients (5%) developed severe hyponatremia (sodium level < 120 mmol/L). Eleven (15.3%) patients required desmopressin replacement immediately post-operatively, and 2 other patients needed desmopressin after discharge and after sodium nadir developed. Hyponatremia was inversely associated with sellar access angle (p = 0.02) and the tumor cranial extension above the sellar floor showing a trend towards significance (p = 0.09).

Conclusion

More than half of patients who had pituitary transposition developed transient hyponatremia. Hyponatremia was more common in those with narrower sellar access angle and smaller cranial extension of the tumor above the sellar floor. Anatomical/surgical parameters may allow risk-stratification for post-operative hyponatremia following pituitary transposition.
Literature
6.
8.
go back to reference Rejane-Heim TC et al (2021) “Surgical anatomy and nuances of the expanded endonasal transdorsum sellae and posterior clinoidectomy approach to the interpeduncular and prepontine cisterns: a stepwise cadaveric dissection of various pituitary gland transpositions,” Acta Neurochir, vol. 163, no. 2, pp. 407–413, https://doi.org/10.1007/s00701-020-04590-5 Rejane-Heim TC et al (2021) “Surgical anatomy and nuances of the expanded endonasal transdorsum sellae and posterior clinoidectomy approach to the interpeduncular and prepontine cisterns: a stepwise cadaveric dissection of various pituitary gland transpositions,” Acta Neurochir, vol. 163, no. 2, pp. 407–413, https://​doi.​org/​10.​1007/​s00701-020-04590-5
14.
go back to reference Bohl M et al (Jan. 2016) Delayed hyponatremia is the most common cause of 30-Day unplanned readmission after transsphenoidal Surgery for pituitary tumors. Neurosurgery 78(1):84–90 Bohl M et al (Jan. 2016) Delayed hyponatremia is the most common cause of 30-Day unplanned readmission after transsphenoidal Surgery for pituitary tumors. Neurosurgery 78(1):84–90
Metadata
Title
Incidence of postoperative hyponatremia after endoscopic endonasal pituitary transposition for skull base pathologies
Authors
Francesca Galbiati
Sharini Venugopal
Hussam Abou-Al-Shaar
Georgios A. Zenonos
Paul A. Gardner
Pouneh K. Fazeli
Hussain Mahmud
Publication date
25-11-2023
Publisher
Springer US
Published in
Pituitary / Issue 1/2024
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-023-01363-y

Other articles of this Issue 1/2024

Pituitary 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.